UBS GROUP AG (UBS)
NYSEFinancialsBanks - DiversifiedSnapshot 2026-11-04
$50.67+5.56%
Close 2026-11-04 · 1-day change
NYSEFinancialsBanks - DiversifiedSnapshot 2026-11-04
Research Workspace
Put UBS beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Financials is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisModerate volatility — typically moves about 1% a day.
View RiskNot enough reads yet
UBS's valuation rests on its role as a major global bank. The desk lacks a clean earnings history to confirm growth. The last reported result was a 7% miss. We cannot anchor a clean multiple for UBS right now. The price is roughly in line with the growth we forecast. The market cycle is currently in a Mania phase. Our model puts the next-quarter miss probability near 23%. Peer multiples imply a price about 12% below where it trades. This read is provisional.
Trailing returns as of 2026-11-04. UBS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 3 analysts currently covering UBS (as of Nov 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare UBS with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| UBS Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 1 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Financials (broad) — fair value, gap to price, and forward P/E.
Compare the value case
Put UBS next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Cost discipline supports margin recovery post-merger.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Cost cuts support integration efficiency thesis.
Positive China performance supports UBS's strategic growth and revenue diversification.
UBS upgrade signals positive view on Rivian.
Cost savings exceed expectations, boosting profitability outlook.
Swiss scrutiny of relocation highlights regulatory and political barriers to UBS moving its headquarters.
Large planned buyback and sub-70% cost-income target support capital returns and efficiency.
Higher quarterly profit and accelerated buybacks support earnings and shareholder returns.
